Skip to main content
Year archive

Orexo — 2020 filings

All 33 regulatory filings released by Orexo (ORX) in 2020, sourced directly from the official regulator.

33 Filings
2020 Period
2020 filings (33)
Filing Released Lang
Correction notice of press release – Q3 2020 Interim Report – ZUBSOLV® guiding 2020
Regulatory Filings
2020-11-04 English
Rättelse av pressmeddelande – delårsrapport – ZUBSOLV® guidning 2020
Earnings Release 9M 2020
2020-11-04 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q3 2020
2020-11-04 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q3 2020
2020-11-04 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-09-28 English
Orexo har mottagit ett paragraf IV-meddelande för ZUBSOLV® i USA
Legal Proceedings Report
2020-08-10 Swedish
Orexo receives paragraph IV Notice Letter for ZUBSOLV® in the US
Legal Proceedings Report
2020-08-10 English
Interim / Quarterly Report 2020
Interim / Quarterly Report Q2 2020
2020-07-16 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Q2 2020
2020-07-16 English
Orexo launches deprexis® and vorvida® in the US and provides updated financial guidance
Regulatory Filings
2020-07-02 English
Orexo lanserar deprexis® och vorvida® i USA och ger uppdaterad finansiell guidning
Earnings Release FY 2020
2020-07-02 Swedish
Number of shares and votes in Orexo
Share Issue/Capital Change
2020-05-29 English
Antal aktier och röster i Orexo
Declaration of Voting Results & Voting Rights Announcements
2020-05-29 Swedish
Report from Orexo AB’s extraordinary general meeting, 19 May 2020
AGM Information
2020-05-19 English
Kommuniké från Orexo AB:s extra bolagsstämma den 19 maj 2020
AGM Information
2020-05-19 Swedish
Orexo förvärvar exklusiva rättigheter för kommersialisering av deprexis® i USA, en världsledande digital terapi för att hjälpa patienter med depressionssymtom
Regulatory Filings
2020-05-11 Swedish
Orexo acquires exclusive US rights to commercialize deprexis®, a world-leading digital therapy to help patients manage the symptoms of depression
M&A Activity
2020-05-11 English
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-04-28 English
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-04-28 Swedish
Kallelse till extra bolagsstämma i Orexo
AGM Information
2020-04-16 Swedish
Notice of Extraordinary General Meeting of Orexo
AGM Information
2020-04-16 English
Kommuniké från Orexo:s årsstämma den 16 april 2020
Declaration of Voting Results & Voting Rights Announcements
2020-04-16 Swedish
Report from Orexo´s annual general meeting, 16 April 2020
AGM Information
2020-04-16 English
Orexo avslutar återköpsprogram
Transaction in Own Shares
2020-04-06 Swedish
Orexo ends share buy-back program
Transaction in Own Shares
2020-04-06 English
Annual Report 2019
Annual Report FY 2019
2020-03-26 Swedish
Annual Report 2019
Annual Report FY 2019
2020-03-26 English
Kallelse till årsstämma i Orexo
AGM Information
2020-03-16 Swedish
Notice of Annual General Meeting of Orexo
AGM Information
2020-03-16 English
Orexo AB (publ.) has resolved to carry out repurchases of own shares
Transaction in Own Shares
2020-02-17 English
Orexo AB (publ) har beslutat att genomföra återköp av egna aktier
Transaction in Own Shares
2020-02-17 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q4 2019
2020-01-30 Swedish
Earnings Release 2019
Earnings Release Q4 2019
2020-01-30 English